AZTA
Azenta, Inc.Price & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA - Continuing Operations non-GAAP | $8M | Q2 FY2026 | — |
| Adjusted EBITDA Margin - Continuing Operations non-GAAP | 5.4% | Q2 FY2026 | — |
| Organic growth | -3% | Q2 FY2026 | — |
| adjusted EBITDA margin non-GAAP | 5.4% | Q2 2026 call | — |
| on-time delivery | 70% | Q2 2026 call | — |
| organic revenue non-GAAP | -3% | Q2 2026 call | — |
| Adjusted gross margin non-GAAP | 44.1% | Q1 FY2026 | — |
| Adjusted operating income non-GAAP | $0.5M | Q1 FY2026 | — |
| Adjusted operating margin non-GAAP | 0.4% | Q1 FY2026 | — |
| Operating cash flow | $21M | Q1 FY2026 | — |
| Organic revenue growth non-GAAP | -1% | Q1 FY2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AZTA
this stock
Azenta, Inc.
|
$1.23B | -19.7% | +3.6% | — | 13.5% |
|
ISRG
Intuitive Surgical Inc
|
$137.76B | -31.3% | +20.5% | 47.3 | 2.1% |
|
MDLN
Medline Inc.
|
$53.74B | -6.1% | +11.5% | — | 2.8% |
|
BDX
Becton Dickinson & Co
|
$42.68B | +2.9% | +8.2% | 58.9 | 4.1% |
|
ALC
Alcon Inc
|
$34.44B | -13.1% | +10.5% | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AZTA | +9.0% | +16.4% | -33.8% | +4.7% | -19.7% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | +7.7% | +16.5% | -44.0% | +3.6% | -30.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.